Sanofi

Results: 1192



#Item
971

PDF Document

Add to Reading List

Source URL: www.fnlm.org

Language: English - Date: 2011-08-22 15:36:00
972Microsoft Word - MKT26616 Imogam Post Exposure Form - Final

Microsoft Word - MKT26616 Imogam Post Exposure Form - Final

Add to Reading List

Source URL: www.vaccineshoppe.com

Language: English - Date: 2013-07-19 15:31:32
973ABIRISK Making novel drugs safer for patients A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments

ABIRISK Making novel drugs safer for patients A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments

Add to Reading List

Source URL: www.imi.europa.eu

Language: English - Date: 2012-06-07 01:42:06
974Participants: PhD students, master students, postdoctoral researchers / junior scientists at the beginning of their career (in academia or industry) Registration Registration fee: Participants from academic institutions

Participants: PhD students, master students, postdoctoral researchers / junior scientists at the beginning of their career (in academia or industry) Registration Registration fee: Participants from academic institutions

Add to Reading List

Source URL: www.uni-regensburg.de

Language: English - Date: 2014-06-25 08:07:48
975Defective Medicines Report Centre Market Towers 1 Nine Elms Lane London SW8 5NQ Telephone: +[removed]2574

Defective Medicines Report Centre Market Towers 1 Nine Elms Lane London SW8 5NQ Telephone: +[removed]2574

Add to Reading List

Source URL: www.mhra.gov.uk

Language: English - Date: 2008-08-25 05:30:15
976COMMUNIQUÉ DE PRESSE Sanofi et Regeneron annoncent les résultats positifs d’une étude de Phase 2b du dupilumab dans le traitement de la dermatite atopique modérée à sévère – Publication aujourd’hui des ré

COMMUNIQUÉ DE PRESSE Sanofi et Regeneron annoncent les résultats positifs d’une étude de Phase 2b du dupilumab dans le traitement de la dermatite atopique modérée à sévère – Publication aujourd’hui des ré

Add to Reading List

Source URL: www.sanofi.com

Language: French - Date: 2014-07-09 16:57:14
    977PRESS RELEASE First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia[removed]% reduction of Dengue Haemorrhagic Fever shown in detailed analyses of world’s

    PRESS RELEASE First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia[removed]% reduction of Dengue Haemorrhagic Fever shown in detailed analyses of world’s

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-07-11 04:42:16
    978Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC - Companies anticipate providing over-the-counter (OTC) product to treat erectile dysfunction after expiration of certain patents PARIS, France,

    Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC - Companies anticipate providing over-the-counter (OTC) product to treat erectile dysfunction after expiration of certain patents PARIS, France,

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-05-28 00:01:30
    979SANOFI KEY FACTS & FIGURES WE ARE a global healthcare leader focused on patients’ needs with a diversified offer of medicines,

    SANOFI KEY FACTS & FIGURES WE ARE a global healthcare leader focused on patients’ needs with a diversified offer of medicines,

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-05-20 11:19:41
    980PRESS KIT WORLD MALARIA DAY MORE THAN 200 MILLION

    PRESS KIT WORLD MALARIA DAY MORE THAN 200 MILLION

    Add to Reading List

    Source URL: en.sanofi.com

    Language: English - Date: 2014-06-24 04:44:12